Common Equity: The sum of all common equity items.
ReShape Lifesciences Inc. (RSLS) had Common Equity of $-0.25M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$1.80M |
|
$-1.76M |
|
$0.49M |
|
$1.32M |
|
$3.51M |
|
$-1.70M |
|
$-0.05M |
|
$-1.76M |
|
$-1.76M |
|
$-1.76M |
|
$-1.76M |
|
$-1.76M |
|
$-1.76M |
|
$-1.70M |
|
$-1.59M |
|
0.02M |
|
0.02M |
|
$-49.98 |
|
$-49.98 |
|
| Balance Sheet Financials | |
$4.59M |
|
$0.04M |
|
$0.20M |
|
$4.79M |
|
$4.99M |
|
-- |
|
$0.06M |
|
$5.05M |
|
|
Common Equity |
$-0.25M |
$-0.25M |
|
$-0.25M |
|
0.03M |
|
| Cash Flow Statement Financials | |
$-4.43M |
|
-- |
|
$0.68M |
|
$4.56M |
|
$0.79M |
|
$-3.77M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.92 |
|
-- |
|
-- |
|
-- |
|
-3.21 |
|
73.07% |
|
-94.35% |
|
-94.35% |
|
-- |
|
-97.34% |
|
-97.56% |
|
$-4.43M |
|
-- |
|
-- |
|
-- |
|
0.38 |
|
0.20 |
|
1.83 |
|
49.21 |
|
696.08% |
|
696.05% |
|
-36.74% |
|
696.05% |
|
$-8.66 |
|
$-214.49 |
|
$-214.49 |
|